About MEDCURA, INC
Medcura is a company developing biopolymer-based hemostatic solutions, including LifeGel™, designed to address surgical bleeding challenges, particularly in confined spaces like spine surgery. Their technology focuses on mechanical hemostasis through mucoadhesion, aiming to reduce risks such as nerve injury and paralysis.
Development of biopolymer-based hemostatic solutionsMechanical hemostasis via mucoadhesionDesign of flowable hemostatic gel for confined surgical spacesFocus on reducing risks like nerve injury and paralysis during spine surgery
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MEDCURA, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.